Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing
J Therm Biol
Mitochondrial quality control in acute ischemic stroke
This indicates a systemic failure to properly transport and utilize lipid fuels
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial
LV volumes and ejection fraction were not different between PCD patients, carriers and healthy subjects
US$ 25.54
US$ 29.77
US$ 28.45
